RxNorm Names
NIGHTTIME SLEEP EASY
(diphenhydramine hcl)
tablet
[P and L Development of New York Corporation]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9003d56b-d930-4876-b074-75e360a4fd01| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph final |
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Warnings
Do not usewith any other products containing diphenhydramine, even one used on skin in children under 12 years of age
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to an enlarged prostate gland glaucoma
When using this product
- drowsiness will occur
- avoid alcoholic drinks
- do not drive a motor vehicle or operate machinery
Directions
Do not take more than directed.
Adults and children 12 years of age and over: take 2 caplets at betime if needed or as directed by a doctor
Children under 12 years of age: do not use.
Other information
each caplet contains (calcium 25mg)
store at controlled room temperature 15-30 degrees C (59 - 86 degrees F)
avoid excessive heat and humidity
Inactive Ingredients
carunauba wax*, colloidal silicon dioxide*, croscarmellose sodium, dibasic calcium phosphate dihydrate, FDandC blue #1 aluminum lake, magnesium stearate, microcyrstalline cellulose, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide * contains one or more of these ingredients.
| NIGHTTIME SLEEP EASY
diphenhydramine hcl tablet |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| Labeler - P and L Development of New York Corporation (800014821) |
Revised: 12/2012
Document Id: e62f2525-39c6-4e49-9a2a-a5fcb2de15f7
Set id: 9003d56b-d930-4876-b074-75e360a4fd01
Version: 1
Effective Time: 20121204
P and L Development of New York Corporation
Review RxNorm Normal Forms